Head-to-head dispatch
Navio MD vs Sprout Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
NavioMD offers compounded tirzepatide ($247/mo) plus brand-name Ozempic ($1,199/mo) and Mounjaro ($1,249/mo).
Marked down on: Not available in Alabama and Mississippi
Desk Score
A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
Marked down on: FDA issued Sprout Health Partners LLC dba Sprout Health a warning letter in September 2025; the letter is public in FDA's warning-letter database
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Sprout Health takes this head-to-head with the higher Desk Score, 86/100 (B) against 79/100 (C+) for Navio MD. Navio MD still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Navio MD
79/100
C+
Sprout Health
86/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Navio MD | Sprout Health |
|---|---|---|
| Semaglutide | $345/mo (starting dose, brand-name) | $299/mo |
| Tirzepatide | $189/mo (starting dose, compounded) | $349/mo |
| Coverage | 48 states | Not disclosed |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who want compounded tirzepatide with brand-name fallback across 48 states. | Patients who want a low compounded entry price but the option of brand-name Wegovy or Zepbound on the same account, with minimal onboarding. |
| Desk Score | 79/100C+ | 86/100B |
The verdict
Desk pick — Sprout HealthSprout Health takes this head-to-head with the higher Desk Score, 86/100 (B) against 79/100 (C+) for Navio MD. Navio MD still holds its ground where its strengths line up with yours.
Choose Navio MD if…
Readers who want compounded tirzepatide with brand-name fallback across 48 states.
$345/mo (starting dose, brand-name) sema · $189/mo (starting dose, compounded) tirz · 48 states
Choose Sprout Health if…
Patients who want a low compounded entry price but the option of brand-name Wegovy or Zepbound on the same account, with minimal onboarding.
$299/mo sema · $349/mo tirz · Not disclosed
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Navio MD · Sprout Health.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Navio MD vs CoreAge Rx
- Sprout Health vs Vaylen
- Navio MD vs Strut Health
- Sprout Health vs Ondra Health
- Navio MD vs Invigor Medical
- Sprout Health vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.